Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators.

Authors:
Segura-Collar B; Hiller-Vallina S; de Dios O; Caamaño-Moreno M; Mondejar-Ruescas L and 2 more

Journal:
Acta Neuropathol Commun

Publication Year: 2023

DOI:
10.1186/s40478-023-01569-y

PMCID:
PMC10171733

PMID:
37165457

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Acta Neuropathol Commun

Abbreviation: Acta Neuropathol Commun

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A rare non-gadolinium enhancing sarcoma brain metastasis with microenvironment dominated by tumor-a…
Rogawski D; Wheeler J; Nie E and 9 more (2024) - Transparency Score: 3/6
Astrocytic accumulation of tau fibrils isolated from Alzheimer's disease brains induces inflammatio…
Eltom K; Mothes T; Libard S and 2 more (2024) - Transparency Score: 3/6
Bi-directional regulation of AIMP2 and its splice variant on PARP-1-dependent neuronal cell death; …
Lee MH; Um KH; Lee SW and 8 more (2024) - Transparency Score: 3/6
CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T…
Tauziède-Espariat A; Lew-Derivry L; Abbou S and 15 more (2024) - Transparency Score: 3/6
CNS tumor with CREBBP::BCORL1 Fusion and pathogenic mutations in BCOR and CREBBP: expanding the spe…
Barresi V; Cardoni A; Miele E and 5 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Competing interestsThe authors declare no conflict of interest. Competing interests The authors declare no conflict of interest."

Evidence found in paper:

"This study has been funded by Instituto de Salud Carlos III (ISCIII) through the project “CP21/00116 and PI22/0117” and co-funded by the Euro­pean Union to RG, by “Asociación Española contra el Cancer (AECC) grant: INVES192GARG to RG and by Ministerio de Ciencia e Innovación and FEDER funds: PI21/01406 to JMSS. Author contributions: Designing research studies: BSC, SHV, and RG; Acquiring data: BSC, SHV, and RG; Writing-Original Draft: BSC, SHV, OD, MCM, LMR and RG; Writing-Review & Editing: BSC, SHV, OD, MCM, LMR, JMSS and RG; Funding Acquisition: RG and JMSS; Supervision: BSC and RG."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025